Charles Ricordel

Efficacy and Safety of Anti–PD-1 Immunotherapy in Patients With Advanced NSCLC With BRAF, HER2, or MET Mutations or RET Translocation: GFPC 01-2018

Florian Guisier, Catherine Dubos‐Arvis, F. Viñas et al. · Journal of Thoracic Oncology · 2020 · 296 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma

Charlotte Domblides, Karen Leroy, I. Monnet et al. · Journal of Thoracic Oncology · 2020 · 136 citations · Full text

Life Sciences, Immunology, Oncology +14

High-flow nasal oxygen: a safe, efficient treatment for COVID-19 patients not in an ICU

Tiphaine Guy, Audrey Créac'hcadec, Charles Ricordel et al. · European Respiratory Journal · 2020 · 79 citations · Full text

Medicine, Critical Care Nursing, Ventilation +10

Ambulatory Management of Large Spontaneous Pneumothorax With Pigtail Catheters

Fanny Voisin, L. Sohier, Y. Rochas et al. · Annals of Emergency Medicine · 2014 · 69 citations

Medicine, Surgery, Pulmonology +7

High Prevalence of Somatic Oncogenic Driver Alterations in Patients With NSCLC and Li-Fraumeni Syndrome

Laura Mezquita, Maria Jové, Ernest Nadal et al. · Journal of Thoracic Oncology · 2020 · 55 citations

Medicine, Genetics, Oncology +16